Recent Publications

1. Zhou S, Hassan A, Kungyal T, Tabaries S, Luna J, Siegel PM, Philip A: CD109 Is a Critical Determinant of EGFR Expression and Signaling, and Tumorigenicity in Squamous Cell Carcinoma Cells. Cancers 2022, 14(15):3672.

2. Drucker AK, Omer; Abbas, Mariam; Alhusayen, Raed; Barnard, Kathleen; Cenedese, Lisa; Chen, Tiffany; Cheng, Yee Sing; Cole, Trish; De Iuliis, Jacob; Desaulniers, Katherine; Duffy, Catherine; Dutz, Jan; Ferris, Tracy; Fradette, Julie; Germain, Lucie; Gniadecki, Robert; Hanna, Sameh; Humeny, Rhiannon; Joseph, Marissa; Khan, Ushra; Litvinov, Ivan; Logsetty, Sarvesh; Lynde, Charles; Manion , Rachael ; Manolson, Morris; Morrison, Steven; Mydlarski, P. Régine ; Ogunyemi, Boluwaji; Piguet, Vincent ; Philip, Anie; Prajapati, Vimal; Ramien, Michele; Reynolds, Lauren; Rosen, Cheryl; Seguin, Kimberly; Sibbald, Cathryn; Swan, Jennifer; Timgren, Jodi; Turchin, Irina; Verner, Vicky; Walsh, Sandra; Ward, Debbie; Weston, Veronica; Zhou, Youwen; Chan, An-Wen: Top ten research priorities for psoriasis, atopic dermatitis and hidradenitis suppurativa: the SkIN Canada Priority Setting Initiative. Journal of Cutaneous Medicine and Surgery 2022.

3. Brooks SGP, Megan; Litvinov, Ivan; Fradette, Julie; Chan, An-Wen; Philip, Anie; Croitoru, David; Richardson, Katlyn: Informing a Canadian Dermatological Science Trainee Program based on the State of Trainee Programs Offered by International Academic Societies. Journal of Cutaneous Medicine and Surgery 2022, In press.

4. Ghanbari F, Fortier AM, Park M, Philip A: Cholesterol-Induced Metabolic Reprogramming in Breast Cancer Cells Is Mediated via the ERRalpha Pathway. Cancers 2021, 13(11).

5. Ghanbari F, Mader S, Philip A: Cholesterol as an endogenous ligand of ERRa promotes ERRa-mediated cellular proliferation and metabolic target gene expression in breast cancer cells. Cells 2020, 9(8):1765.

6. Zhou S, da Silva SD, Siegel PM, Philip A: CD109 acts as a gatekeeper of the epithelial trait by suppressing epithelial to mesenchymal transition in squamous cell carcinoma cells in vitro. Scientific reports 2019, 9(1):16317.

7. Istomine R, Alvarez F, Almadani Y, Philip A, Piccirillo CA: The deubiquitinating enzyme ubiquitin-specific peptidase 11 potentiates TGF-b signaling in CD4(+) T Cells to facilitate Foxp3(+) regulatory T and TH17 cell differentiation. J Immunol 2019, 203(9):2388-2400.

8. Ghanbari F, Hebert-Losier A, Barry J, Poirier D, Giguere V, Mader S, Philip A: Isolation and functional characterization of a novel endogenous inverse agonist of estrogen related receptors (ERRs) from human pregnancy urine. The Journal of steroid biochemistry and molecular biology 2019, 191:105352

9. Finnson KW, Almadani Y, Philip A: Non-canonical (non-SMAD2/3) TGF-b signaling in fibrosis: mechanisms and targets. Semin Cell Dev Biol 2019, 101:115-122.

10. Alzahrani A, Chi Y, Finnson KW, Blati M, Lussier B, Kapoor M, Roy S, Philip A: Endoglin haploinsufficiency is associated with differential regulation of extracellular matrix production during skin fibrosis and cartilage repair in mice. J Cell Commun Signal 2018, 12(1):379-388.

11. Zhou S, Cecere R, Philip A: CD109 released from human bone marrow mesenchymal stem cells attenuates TGF-b-induced epithelial to mesenchymal transition and stemness of squamous cell carcinoma. Oncotarget 2017, 8(56):95632-95647.

12. Vorstenbosch J, Nguyen CM, Zhou S, Seo YJ, Siblini A, Finnson KW, Bizet AA, Tran SD, Philip A: Overexpression of CD109 in the epidermis differentially regulates ALK1 versus ALK5 signaling and modulates extracellular matrix synthesis in the skin. The Journal of investigative dermatology 2017, 137(3):641-649.

 

 

Back to top